|Bid||4.4200 x 900|
|Ask||4.6300 x 1000|
|Day's range||4.4500 - 4.6200|
|52-week range||2.1000 - 13.0000|
|Beta (5Y monthly)||0.83|
|PE ratio (TTM)||N/A|
|Earnings date||11 Nov 2020 - 16 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||20.30|
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Biocept (BIOC) is expected to have suffered in Q2 from reduced oncology practices and postponement of patient appointments.
It's been a good week for Biocept, Inc. (NASDAQ:BIOC) shareholders, because the company has just released its latest...